ESSA Pharma (EPIX) News Today $1.72 -0.03 (-1.71%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.72 0.00 (0.00%) As of 02/21/2025 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitFebruary 22 at 10:26 AM | prnewswire.comESSA Pharma (NASDAQ:EPIX) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Above Fifty Day Moving Average - What's Next?February 22 at 4:59 AM | marketbeat.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 21 at 4:00 PM | globenewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIXFebruary 21 at 1:42 PM | globenewswire.comESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXFebruary 21 at 5:45 AM | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 20 at 7:25 PM | globenewswire.comClass Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors – Contact The Gross Law FirmFebruary 20 at 1:22 PM | globenewswire.comFaruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXFebruary 20 at 10:22 AM | prnewswire.comInvestors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIXFebruary 20 at 5:45 AM | prnewswire.comInvestors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class Action - EPIXFebruary 18, 2025 | globenewswire.comESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIXFebruary 18, 2025 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. ...February 17, 2025 | gurufocus.comROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 17, 2025 | globenewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 17, 2025 | investing.comROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 16, 2025 | investing.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. ...February 16, 2025 | gurufocus.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 16, 2025 | globenewswire.comEPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitFebruary 16, 2025 | gurufocus.comEPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud LawsuitFebruary 16, 2025 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 14, 2025 | investing.comEPIX STOCK NEWS: EPIX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Essa Pharma Inc.February 14, 2025 | globenewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 14, 2025 | globenewswire.comLevi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIXFebruary 14, 2025 | prnewswire.comLevi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – EPIXFebruary 13, 2025 | globenewswire.comClass Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact The Gross Law FirmFebruary 13, 2025 | prnewswire.comESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIXFebruary 12, 2025 | globenewswire.comROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 11, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIXFebruary 11, 2025 | prnewswire.comESSA Pharma (NASDAQ:EPIX) Posts Earnings Results, Misses Expectations By $0.01 EPSESSA Pharma (NASDAQ:EPIX - Get Free Report) (TSE:EPI) issued its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.01).February 11, 2025 | marketbeat.comEssa Pharma reports Q4 EPS (19c) vs. (14c) last yearFebruary 11, 2025 | markets.businessinsider.comESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024February 11, 2025 | prnewswire.comESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIXFebruary 11, 2025 | prnewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 10, 2025 | globenewswire.comClass Action Filed Against ESSA Pharma Inc. ...February 10, 2025 | gurufocus.comClass Action Filed Against ESSA Pharma Inc. (EPIX) - March 25, 2025 Deadline to Join - Contact The Gross Law FirmFebruary 10, 2025 | prnewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. ...February 9, 2025 | gurufocus.comROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. ...February 8, 2025 | gurufocus.comROSEN, A TOP RANKED LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 8, 2025 | globenewswire.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 7, 2025 | investing.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 7, 2025 | prnewswire.comLevi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – EPIXFebruary 7, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA PharmaFebruary 7, 2025 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIXFebruary 6, 2025 | globenewswire.comClass Action Filed Against ESSA Pharma Inc. (EPIX) - March 25, 2025 Deadline to Join - Contact The Gross Law FirmFebruary 6, 2025 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIXFebruary 5, 2025 | globenewswire.comClass Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for Investors - Contact Levi & KorsinskyFebruary 5, 2025 | markets.businessinsider.comShareholder Rights Law Firm Robbins LLP Urges EPIX Shareholders with Large Losses to Seek Counsel for the ESSA Pharma Inc. Class ActionFebruary 4, 2025 | prnewswire.comEPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that ESSA Pharma Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 4, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIXFebruary 4, 2025 | prnewswire.comLevi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIXFebruary 4, 2025 | globenewswire.com Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address EPIX Media Mentions By Week EPIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPIX News Sentiment▼0.080.60▲Average Medical News Sentiment EPIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPIX Articles This Week▼182▲EPIX Articles Average Week Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aquestive Therapeutics News Gossamer Bio News Candel Therapeutics News Atyr PHARMA News Immutep News Olema Pharmaceuticals News Korro Bio News Neumora Therapeutics News Y-mAbs Therapeutics News Kodiak Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EPIX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
